Learning Objectives:

1. Articulate the evidence supporting the link between the gut microbiome and its effect on cancer therapies

2. Discuss novel strategies to modulate the gut microbiome to optimize efficacy of PD-1 based immunotherapy

Session date: 
11/05/2021 - 8:00am to 9:30am CDT
United States
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation

Please login or create an account to proceed.
Speaker Name: 
Carolina Soto Chervin, MD, PhD